Onconetix Inc. (ONCO)
NASDAQ: ONCO
· Real-Time Price · USD
2.94
-0.15 (-4.85%)
At close: Aug 15, 2025, 3:59 PM
2.91
-1.14%
After-hours: Aug 15, 2025, 07:31 PM EDT
Onconetix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 101.63K | 711.98K | 406.86K | 704.85K | 700.43K | 58.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 55.8K | 52.01K | 301.44K | 604.13K | 542.43K | 1.19M | 1.62K | 1.57K | 1.7K | 1.85K | 1.84K | 1.76K | 1.3K | 1.15K | 1.26K | 1.23K |
Gross Profit | 45.83K | 659.97K | 105.41K | 100.72K | 158K | -1.14M | -1.62K | -1.57K | -1.7K | -1.85K | -1.84K | -1.76K | -1.3K | -1.15K | -1.26K | -1.23K |
Operating Income | -12.57M | -29.15M | -2.65M | -13.62M | -3.6M | -5.39M | -4.49M | -6.65M | -2.85M | -3.25M | -3.87M | -4.29M | -1.71M | -1.2M | -1.1M | -325.78K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.55M | -30.36M | -3.88M | -14.26M | -11.24M | -22.36M | -5.35M | -6.87M | -2.85M | -3.22M | -3.87M | -4.26M | -2.07M | -1.2M | -1.1M | -325.78K |
Net Income | -8.55M | -29.44M | -3.83M | -14.31M | -11.12M | -22.35M | -5.35M | -6.87M | -2.85M | -3.22M | -3.87M | -4.26M | -2.07M | -1.2M | -1.1M | -325.78K |
Selling & General & Admin | 1.67M | 2.66M | 2.64M | 2.22M | 3.71M | 4.26M | 4.27M | 2.3M | 1.77M | 2.04M | 2.69M | 3M | 1.25M | 764.88K | 824.74K | 236.31K |
Research & Development | 24.45K | -290 | 109.36K | -3.68K | 48.96K | -198.92K | 219.24K | 846.85K | 1.08M | 1.21M | 1.18M | 1.29M | 455.09K | 437.33K | 269.93K | 88.24K |
Other Expenses | 10.92M | 27.14M | n/a | 11.5M | n/a | 4.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.62M | 29.81M | 2.75M | 13.11M | 3.75M | 4.26M | 4.49M | 3.15M | 2.85M | 3.24M | 3.87M | 4.29M | 1.71M | 1.2M | 1.09M | 324.55K |
Interest Expense | 223.59K | 248.35K | 384.96K | 361.31K | 413.06K | 188.53K | 269.1K | 214K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -2.17M | n/a | n/a | n/a | -1.85K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.67M | 29.86M | 3.05M | 13.72M | 4.3M | 5.45M | 4.49M | 3.15M | 2.85M | 3.25M | 3.87M | 4.29M | 1.71M | 1.2M | 1.1M | 325.78K |
Income Tax Expense | n/a | -918K | -56.38K | 50.77K | -121.57K | -12.59K | n/a | n/a | -1.61K | 4.00 | 5.00 | n/a | n/a | -3 | n/a | -2 |
Shares Outstanding (Basic) | 5.34K | 2.75M | 1.31M | 22.2M | 22.15M | 22.32M | 17.52M | 15.91M | 15.91M | 15.27M | 14.34M | 12M | 6.34M | 11.05M | 11.05M | 3.2M |
Shares Outstanding (Diluted) | 5.34K | 2.75M | 1.31M | 22.2M | 22.15M | 22.32M | 17.52M | 15.91M | 15.91M | 15.27M | 14.34M | 12M | 6.34M | 11.05M | 11.05M | 3.2M |
EPS (Basic) | -1.8K | -17.38 | -2.93 | -0.64 | -0.5 | -1 | -0.31 | -0.43 | -0.18 | -0.21 | -0.27 | -0.36 | -0.33 | -0.11 | -0.1 | -0.1 |
EPS (Diluted) | -1.8K | -17.38 | -2.93 | -0.64 | -0.5 | -1 | -0.31 | -0.43 | -0.18 | -0.21 | -0.27 | -0.36 | -0.33 | -0.11 | -0.1 | -0.1 |
EBITDA | -8.32M | -29.99M | -3.29M | -13.69M | -10.62M | -22.14M | -5.08M | -6.65M | -2.84M | -3.24M | -3.86M | -4.26M | -2.07M | -1.2M | -1.09M | -324.55K |
EBIT | -8.32M | -30.11M | -3.5M | -13.89M | -10.83M | -22.17M | -5.08M | -6.65M | -2.85M | -3.25M | -3.87M | -4.26M | -2.07M | -1.2M | -1.1M | -325.78K |
Depreciation & Amortization | 4.75K | 119.3K | 204.04K | 201.3K | 206.7K | 39.05K | 1.62K | 1.57K | 1.7K | 1.85K | 1.84K | 1.76K | 1.3K | 1.15K | 1.26K | 1.23K |